Kodiak Sciences Inc.

NasdaqGM:KOD Stock Report

Market Cap: US$197.4m

Kodiak Sciences Future Growth

Future criteria checks 0/6

Kodiak Sciences's earnings are forecast to decline at 8.2% per annum. EPS is expected to grow by 24.4% per annum.

Key information

-8.2%

Earnings growth rate

24.4%

EPS growth rate

Biotechs earnings growth24.0%
Revenue growth raten/a
Future return on equity-493.2%
Analyst coverage

Low

Last updated10 Apr 2024

Recent future growth updates

Recent updates

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Apr 17
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Dec 29
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate

Sep 09
We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate

Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Deliver On Growth Plans?

May 26
Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Deliver On Growth Plans?

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Jan 04
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Here's Why We're Watching Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

Sep 25
Here's Why We're Watching Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

GreenWood Investors - Kodiak Sciences: The Busted Biotech World

Aug 25

Kodiak Sciences FQ1 2022 Earnings Preview

Aug 07

Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Invest In Growth?

May 18
Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Invest In Growth?

Kodiak Sciences: Potential For Comeback After Trial Setback

May 17

Kodiak Sciences: KSI-301 Disappoints

Feb 25

Highlighting Kodiak Sciences: A Great Buy Here Ahead Of Phase 3 Wet AMD Data For KSI-301 This Quarter

Feb 15

We're Hopeful That Kodiak Sciences (NASDAQ:KOD) Will Use Its Cash Wisely

Jan 24
We're Hopeful That Kodiak Sciences (NASDAQ:KOD) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

Oct 11
Here's Why We're Not Too Worried About Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

Kodiak Sciences: Our Current Take On This Mid-Cap Biotech Company

Jul 19

Kodiak Sciences EPS in-line

May 10

Kodiak Sciences hits the capital raise button; shares dip after hours

Nov 16

Kodiak Sciences EPS misses by $0.12

Nov 09

Earnings and Revenue Growth Forecasts

NasdaqGM:KOD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025N/A-267-92N/A2
12/31/2024N/A-225-198-1713
12/31/2023N/A-260-196-154N/A
9/30/2023N/A-271-197-177N/A
6/30/2023N/A-298-224-197N/A
3/31/2023N/A-309-252-211N/A
12/31/2022N/A-334-254-206N/A
9/30/2022N/A-357-263-210N/A
6/30/2022N/A-347-286-209N/A
3/31/2022N/A-312-266-191N/A
12/31/2021N/A-267-246-182N/A
9/30/2021N/A-220-208-150N/A
6/30/2021N/A-189-150-123N/A
3/31/2021N/A-159-114-100N/A
12/31/2020N/A-133-90-83N/A
9/30/2020N/A-102-70-68N/A
6/30/2020N/A-78-51-51N/A
3/31/2020N/A-64-50-50N/A
12/31/2019N/A-47-40-39N/A
9/30/2019N/A-46-37-36N/A
6/30/2019N/A-44-34-33N/A
3/31/2019N/A-41-26-25N/A
12/31/2018N/A-41-30-29N/A
9/30/2018N/A-38-26-26N/A
6/30/2018N/A-32-26-26N/A
3/31/2018N/A-31-25-25N/A
12/31/2017N/A-28-18-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: KOD is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: KOD is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: KOD is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if KOD's revenue is forecast to grow faster than the US market.

High Growth Revenue: KOD is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: KOD is forecast to be unprofitable in 3 years.


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.